AUROPHARMA
Aurobindo Pharma LimitedNSEMarket Closed · NSE · INR
Open
₹1,660.5
High
₹1,698.8
Low
₹1,655
Prev Close
₹1,660
Market Cap
₹95.51 K Cr
Large Cap
P/E (TTM)
25.94
EPS
₹64
Div Yield
-
P/B Ratio
3.26
ROE
9.8%
Key Metrics
Analyst Ratings(28 analysts)
Target Price
₹1,678
-0.8% upside
Current price: ₹1,692
What If I Had Invested?
Chart data not available for this range
AI Analysis
Get AI-powered sentiment analysis, strengths, risks, and outlook for this stock.
AI Technical Analysis
Buy/sell zones with live web research
Get AI-generated buy zones, sell targets, stop-loss levels and a technical narrative — powered by AI with live web search for the latest news and analyst moves.
Patterns are measured on real price data, then AI-validated. Pattern detection is free when nothing clean is found.
About
Aurobindo Pharma Limited, a pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally. The company manufactures a range of finished formulation products in various forms, such as oral solids, liquids, injectabl...
Technical Indicators
Quality scores
Valuation bands
Intrinsic value calculators
Peer Comparison
Dividend History
Recent: ₹4.00/shareRecent Filings (NSE)
Raw NSE filings — full text + attachments. Tap any row for an AI summary that explains what it means for the stock.
Institutional Deals(NSE)
Source: NSE India. Block deals ≥5L shares or ≥₹10Cr. Bulk deals ≥0.5% of shares.
Governance Scorecard
AlphaView compositeFund Actions
News
News sourced from RSS feeds. Headlines link to original articles.
Disclaimer: This is AI-generated educational information, not investment advice. Stock data is delayed by up to 15 minutes. Past performance does not guarantee future results. Please consult a SEBI-registered investment advisor before making investment decisions.